These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30239388)

  • 41. [Fever in the neutropenic onco-hematologic patient: critical considerations].
    Garavelli PL
    Recenti Prog Med; 2006 May; 97(5):266. PubMed ID: 16838558
    [No Abstract]   [Full Text] [Related]  

  • 42. Hepatitis C treatment concomitant to chemotherapy as "salvage" therapy in children with hematologic malignancies.
    Papaevangelou V; Varsami M; Papadakis V; Zellos A; Parcharidou A; Papargyri S; Karentzou O; Manolaki N; Roma E; Polychronopoulou S
    Pediatr Infect Dis J; 2010 Mar; 29(3):277-80. PubMed ID: 19949358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Transfusion in haematology].
    Renaudier P
    Transfus Clin Biol; 2008 Nov; 15(5):228-35. PubMed ID: 18930422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemato-oncology and palliative care teams: is it time for an integrated approach to patient care?
    LeBlanc TW; El-Jawahri A
    Curr Opin Support Palliat Care; 2018 Dec; 12(4):530-537. PubMed ID: 30379755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient perspectives on the usefulness of routine telephone follow-up as psychosocial support for hematologic malignancies: Australian findings.
    McGrath P
    Oncol Nurs Forum; 2014 Jan; 41(1):40-4. PubMed ID: 24368238
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Emergency in pediatric hematologic oncology. French Group for the Study of Cancers and Leukemias of the Child (CFECLE)].
    Leverger G; Sommelet D
    Arch Pediatr; 1999; 6 Suppl 2():459s-460s. PubMed ID: 10370569
    [No Abstract]   [Full Text] [Related]  

  • 47. Psychosocial predictors of quality of life in hematological cancer.
    Pulgar Á; Alcalá A; Reyes Del Paso GA
    Behav Med; 2015; 41(1):1-8. PubMed ID: 24965511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The ambulatory cancer patient treated by chemotherapy].
    Bondue H
    Rev Med Brux; 1997 Sep; 18(4):218-20. PubMed ID: 9411646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Issues in adult blood cancer survivorship care.
    Bugos KG
    Semin Oncol Nurs; 2015 Feb; 31(1):60-6. PubMed ID: 25636396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of anemia in patients with hematologic malignancies.
    Straus DJ
    Oncology (Williston Park); 2006 Jul; 20(8 Suppl 6):8-11. PubMed ID: 16925104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perceived social support and health-related quality of life in AYA cancer survivors and controls.
    Tremolada M; Bonichini S; Basso G; Pillon M
    Psychooncology; 2016 Dec; 25(12):1408-1417. PubMed ID: 26810123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Nephrological aspects of blood diseases].
    Biriukova LS; Timokhov VS
    Ter Arkh; 2003; 75(6):73-9. PubMed ID: 12920966
    [No Abstract]   [Full Text] [Related]  

  • 53. Dying from hematological cancers.
    Enck RE
    Am J Hosp Palliat Care; 2002; 19(2):79-80. PubMed ID: 11926447
    [No Abstract]   [Full Text] [Related]  

  • 54. Interferon-alpha: a clinical update.
    Rieger PT
    Cancer Pract; 1995; 3(6):356-65. PubMed ID: 15859166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hematologic Malignancies/Pediatric Malignancies New Therapeutic Strategy for Hematologic Malignancies].
    Usui N
    Gan To Kagaku Ryoho; 2018 May; 45(5):793-794. PubMed ID: 30026439
    [No Abstract]   [Full Text] [Related]  

  • 56. Predictors of QoL in renal transplant recipients: bridging the gap between research and clinical practice. Posttransplant Quality of Life Intervention Study Group.
    Winsett RP; Hathaway DK
    ANNA J; 1999 Apr; 26(2):235-40. PubMed ID: 10418354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.
    De Fabritiis P; Dentamaro T; Picardi A; Cudillo L; Masi M; Amadori S
    Haematologica; 2004 Feb; 89(2):243-5. PubMed ID: 15003905
    [No Abstract]   [Full Text] [Related]  

  • 58. Psychiatric and psychosocial challenges in patients undergoing haematopoietic stem cell transplants.
    Rueda-Lara M; Lopez-Patton MR
    Int Rev Psychiatry; 2014 Feb; 26(1):74-86. PubMed ID: 24716502
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences.
    Rood JA; van Zuuren FJ; Stam F; van der Ploeg T; Eeltink C; Verdonck-de Leeuw IM; Huijgens PC
    Hematol Oncol; 2015 Jun; 33(2):85-98. PubMed ID: 24811073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Critically ill cancer patient in intensive care unit: issues that arise.
    Kostakou E; Rovina N; Kyriakopoulou M; Koulouris NG; Koutsoukou A
    J Crit Care; 2014 Oct; 29(5):817-22. PubMed ID: 24857640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.